NKGN

NKGen Biotech, Inc. Common Stock

Insider Trades

NameValueActionPriceCurrent Price
Song Paul Y.Chief Executive Officer
$2.7M20.8M shares
BuyMay 5, 2025
$0.1271
--
Song Paul Y.Chief Executive Officer
$5.3M41.7M shares
BuyMay 5, 2025
$0.1271
--
CFIC-2015 NV Family Investments, LLC10 Percent Owner
$2.5M19.7M shares
BuyMay 27, 2025
$0.1271
--
CFIC-2015 NV Family Investments, LLC10 Percent Owner
$5.0M39.3M shares
BuyMay 27, 2025
$0.1271
--

News

globenewswire.comNKGen Biotech Expands Clinical Trial Site Network for Alzheimer's Disease Program Across U.S. to Improve Patient Access and Support Enrollmentglobenewswire.comMay 19globenewswire.comNKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer's and Frontotemporal Dementia at the Neuroimmunology Drug Development Summitglobenewswire.comApr 9globenewswire.comNKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer's Disease at AD/PD 2026™globenewswire.comMar 23